|
CKS1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65056857071022E-12 |
| Normal-vs-Stage2 |
4.37779999999943E-05 |
| Normal-vs-Stage3 |
1.90509999997701E-06 |
| Normal-vs-Stage4 |
1.26789999610466E-08 |
| Stage1-vs-Stage2 |
4.173800E-01 |
| Stage1-vs-Stage3 |
5.140400E-01 |
| Stage1-vs-Stage4 |
8.088000E-02 |
| Stage2-vs-Stage3 |
2.470400E-01 |
| Stage2-vs-Stage4 |
6.040200E-01 |
| Stage3-vs-Stage4 |
4.818500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.682400E-03 |
| Normal-vs-Asian |
1.509180E-01 |
| Caucasian-vs-AfricanAmerican |
1.367760E-01 |
| Caucasian-vs-Asian |
6.956400E-01 |
| AfricanAmerican-vs-Asian |
2.942000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62547753035369E-12 |
| Normal-vs-Female |
2.39840369786748E-11 |
| Male-vs-Female |
2.494800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.249700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.70235003450171E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6278089987054E-12 |
| Normal-vs-Age(81-100Yrs) |
2.918000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.502000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.789400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.497000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.493600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.055200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.182200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.59520999999385E-05 |
| Normal-vs-Grade 2 |
1.11022302462516E-15 |
| Normal-vs-Grade 3 |
5.7221005711483E-11 |
| Normal-vs-Grade 4 |
5.55500000000153E-05 |
| Grade 1-vs-Grade 2 |
8.296800E-01 |
| Grade 1-vs-Grade 3 |
9.272000E-01 |
| Grade 1-vs-Grade 4 |
6.035200E-01 |
| Grade 2-vs-Grade 3 |
6.690800E-01 |
| Grade 2-vs-Grade 4 |
6.579600E-01 |
| Grade 3-vs-Grade 4 |
5.242400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.56218999999291E-05 |
| ccA subtype-vs-ccB subtype |
1.603990E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14808162976487E-12 |
| Normal-vs-N1 |
3.159000E-03 |
| N0-vs-N1 |
3.192100E-02 |
|
|
